ORI Capital is a healthcare private equity firm founded in 2015 which invests in innovative early-stage biotech companies globally. Our mission is to be both financially successful for our investors and socially impactful to patients worldwide.We invest in the most promising innovations and disruptive technologies in the areas of diagnostics, drug delivery, and therapeutics focused on the disease areas with the highest mortality rates: cancer, cardiovascular and neurodegenerative diseases.